Subgroup analysis showed that these negative prognostic factors, except MxA expression, remained statistically significant for patients with lymph node metastasis, whereas pT, lymphovascular invasion, and MxA expression were effective prognostic factors in patients without lymph node metastasis. This evidence concerns the gene MX1 and metastatic malignant neoplasm in the lymph nodes.